Pharmaceuticals News

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} DXS INTERNATIONAL PLC AGM...

Tomorrow, Thursday, 6 November 2014, AstraZeneca will release third quarter and nine months results 2014 at 07:00 GMT. An analysts presentation of the third quarter and nine months results will...

Valby, Copenhagen, 2014-11-05 07:59 CET (GLOBE NEWSWIRE) --   HIGHLIGHTS New Products up 46% in local currency and 40% reported in the first nine months of the year US revenue was...

RANCHO CUCAMONGA, Calif., Nov. 4, 2014 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) announced that the Company will release results for its third quarter of 2014 ended September...

ROCKVILLE, Md., Nov. 4, 2014 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN) a specialty pharmaceutical company focused on developing and commercializing products for the treatment of...

Revenue of $168.8 million; diluted EPS of $0.21; adjusted EPS of $0.25 myRisk Hereditary Cancer revenue of $53.1 million, up 95 percent sequentially Draft Medicare decision covering...

PALO ALTO, Calif., Nov. 4, 2014 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today...

– Reports Record Revenue, Cash Reimbursement and Test Volumes – – Company to Host Conference Call and Webcast Today at 1:30 p.m. PST – IRVINE, Calif., Nov. 4, 2014 (GLOBE...

REDWOOD CITY, Calif., Nov. 4, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced financial...

EMERYVILLE, Calif., Nov. 4, 2014 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today reported a net loss attributable to common stockholders of $9.6 million, or $0.57 per share, for...